Drug Injection Devices Markets, 2028 - Regulatory Issues, Device Branding, Patient Compliance and Ease of Use, Healthcare Economics, Company Profiles

2022-10-21
PRNewswire
疫苗
DUBLIN, Oct. 21, 2022 /PRNewswire/ -- The "Drug Injection Devices to 2028" report has been added to
ResearchAndMarkets.com's offering.
Drug Injection Devices to 2028 - What You Will Learn
What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
What are the market drivers influencing syringe and injector device designs, feature/functionality, product branding, competing technologies and commercial development?
What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
What is the current market for syringe and injector demand by indication and therapy and what will it be in 2028?
Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?
The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions.
Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers.
For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.
Key Topics Covered:
The Market Opportunity
Injectable Drug Demand Drivers
Syringe Economics
Device Selection - Stability and Material Issues
Injection Device Suppliers Capabilities and Market Presence
North America
Europe
Asia
Commercial Injection Device Classes - Strategic Analysis
Autoinjectors
Manual Injection Autoinjectors
Reusable Autoinjectors
Fixed Dose Autoinjectors
Fixed Dose/Reusable Injectors
Variable Dose Autoinjectors
Syringe-based Autoinjectors
Cartridge Base Autoinjectors
Automated Injection Autoinjectors
Product Specific Autoinjectors
Dual Chamber Pen Injectors
Needle-free Injectors
Pen Injectors
Standardized Pen Platforms
Pen Classes
Reusable Pens
Drug/Device Combination Products
Prefilled Syringes
Glass Prefilled Syringes
COC Prefilled Syringes
Subcutaneous Infusion Devices
Injection Device Selection Criteria
Fixed vs Variable Dose Devices
Lyophilized Drugs/Reconstitution
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling
Drug Injection Device Market Segment Analysis & Forecasts
Anticoagulants
Antivirals
Stelara (Ustekinumab)
Hematopoietics
Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Issues
Patient Compliance and Ease of Use
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/811b1y
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。